BreezeMeds Review 2026: Cardiac-Safety Questions Before Enrollment

By UTCardiothoracicSurgery.com Editorial Team

For someone with cardiovascular disease, the first question is who will review the full medication list and coordinate changes. An unidentified prescription cannot be assessed for individual interactions.

BreezeMeds says it matches applicants with licensed healthcare providers and works with pharmacy partners. Remote access does not replace medication reconciliation, clinician judgment, or an escalation plan.

Build a One-Page Medication Reconciliation

Prepare one current list of prescription medicines, over-the-counter products, vitamins, supplements, allergies, and previous adverse effects. Add schedules, recent changes, and prescribers.

List cardiovascular diagnoses, blood pressure or heart-rate concerns, hospital stays, procedures, and planned anesthesia. Include the heart-care clinician’s contact. This helps the online prescriber check interactions once the medication is identified.

Our cardiac patient safety preparation guide offers a longer discussion framework. It does not establish what BreezeMeds would prescribe or whether an applicant is eligible.

The Missing Prescription Identity Comes First

The captured page does not name the weight-loss medication or active ingredient. It also omits the applicant-specific dose, formulation, concentration, regulatory status, dispensing pharmacy, and medication-specific safety terms. This review cannot assign drug-specific contraindications, benefits, side effects, or heart effects.

Ask the prescriber to identify the proposed product in writing and explain why it is being considered in light of your history. If a compounded option is proposed, its identity should appear in the prescription and pharmacy documents. Compounded drugs are not FDA approved and cannot be described as generic or equivalent to an approved brand. This regulatory boundary does not mean that BreezeMeds will supply a compounded product.

For general background on cardiovascular evidence questions, see our heart-health evidence explainer. Research about a known medicine or class cannot be transferred to an unidentified BreezeMeds injection or used to predict one person’s outcome.

Map the Care Team Before Treatment

BreezeMeds says applicant history, needs, and preferences are used to match users with licensed healthcare providers. It calls its providers board-certified and experienced in weight management. The captured FAQ names Lion MD as a nationwide medical team led by Dr. Ana Lisa Carr, MD, NPI 1689841744, and Dr. Kelly Tenbrink, MD, NPI 1346482684.

Those statements do not identify an applicant’s clinician. BreezeMeds, Lion MD, the prescriber, the cardiology team, and the pharmacy can have different duties. Ask who reviews medicines, monitors progress, responds after hours, and communicates with existing clinicians.

BreezeMeds says it serves all 50 states. That claim does not establish current state eligibility or confirm that an appropriately licensed clinician is available when you apply.

Pharmacy and Shipping Questions Affect Safety

BreezeMeds lists Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx as pharmacy providers. That list does not assign a particular pharmacy to an applicant or establish a formulation, concentration, or batch. Do not infer which pharmacy would dispense until it is confirmed in the applicant’s records.

The company describes discreet shipping. Its FAQ says the process typically runs two to three weeks from consultation to medication receipt, referencing prescription review and expedited delivery. These are seller statements, not a delivery guarantee or complete policy.

Ask how an incorrect label, damaged package, late order, or missing contents are handled. Do not use a questionable shipment until the pharmacy gives instructions.

Separate the Price From the Clinical Plan

BreezeMeds advertises weight-loss injections starting at $199. This does not establish a complete checkout total, universal price, monthly charge, or billing cadence. The capture also leaves consultation costs, included monitoring, shipping fees, future charges, and renewal terms unresolved.

The site separately lists NAD+ injections starting at $169. That is a distinct listing, not the weight-loss prescription, and it does not clarify the $199 offer. NAD+, boosters, patches, and probiotic products remain outside this wave.

BreezeMeds describes pricing as affordable and uses “certified medication” language. Those are seller descriptions, not an independent certification or proof of regulatory approval. The site also says FSA/HSA eligible. Verify the expense with your plan administrator or account custodian.

Results and Privacy Need Careful Attribution

The seller refers to one-to-two pounds of weekly loss and a 15–20% average body-weight loss. It also uses testimonials. These statements are not independent or applicant-specific evidence and should not be treated as typical, promised, or guaranteed results.

BreezeMeds calls the service confidential. Its privacy policy identifies Breezemeds, LLC and says a separate Notice of Privacy Practices governs protected health information connected with care. It describes sharing with medical providers, pharmacies, payment processors, service providers, affiliates, and other listed recipients. These disclosures do not prove privacy or security performance. Read both documents before providing sensitive cardiac or payment information.

Clinical History the Prescriber Should Review

A complete assessment should address pregnancy or breastfeeding, planned anesthesia, allergies, current medications, and prior adverse effects. It should also include personal and family history of medullary thyroid carcinoma or MEN2, plus pancreatitis, gallbladder or kidney disease, severe gastrointestinal disease, and diabetic retinopathy.

These are general screening topics when a clinician considers a GLP-1 medicine, not proof that any particular issue applies to the unidentified BreezeMeds prescription. Individual clinical review and continuing monitoring are essential.

Cardiac-Focused Fit Decision

May be worth considering: An adult who values online access, can produce a complete medication record, can coordinate with existing clinicians, and will obtain terms in writing.

Not appropriate: Anyone seeking emergency care, guaranteed eligibility, a promised prescription or result, or a known total without verification. The privacy policy says services are not knowingly provided to people under 18. Pregnancy, breastfeeding, unstable symptoms, complex medication changes, or limited follow-up require direct clinical guidance.

Our program comparison checklist may help organize the buying decision, but the applicant’s written terms should control.

Questions to Ask Before Any Payment

• What exact medication, ingredient, dose, and formulation would my clinician propose?
• Who will reconcile my cardiac and other medicines, and who monitors changes?
• Is the assigned clinician currently licensed for my state?
• Which pharmacy would dispense, and what are its correction and escalation contacts?
• What is the total charge, billing cadence, included care, and renewal schedule?
• How do cancellation and refunds work, and what is the damaged or incorrect shipment remedy?
• Which symptoms require a routine message, prompt evaluation, or emergency action?

Report adverse effects promptly to the assigned clinician and use the escalation instructions for the actual prescription. An online weight-management program is not emergency care. Call 911 or local emergency services for severe or urgent symptoms.

Medical disclaimer: This article is general information, not medical advice, diagnosis, or treatment. A licensed healthcare professional who knows your full history must determine eligibility, prescribing, monitoring, and coordination. Never start, stop, or change a medicine based on this review.